New Search

If you are not happy with the results below please do another search

40 search results for:

1

FFI-Ventures joins Partex.AI

/0 Comments/in ,
FFI-Ventures joins Partex.AI One partner for the drug lifecycle. Precision AI at scale. We are delighted to announce that FFI Ventures is joining Partex.AI, a partnership built on a shared conviction and delivering opportunity for life science companies. Precision AI, combined with deep scientific and commercial expertise, fundamentally changes how therapies develop and reach patients. [...]
2

Seventy voices, one clear signal: AI is no longer optional

/0 Comments/in ,
Reflections from the 3rd AI Forum in Pharma, co-hosted by SHQA and FFI Ventures at the Novartis campus in Rotkreuz in Switzerland, June 11, 2026. Two years ago, the first SHQA-FFI AI Forum asked a simple question: What could AI mean for Pharma? This year, that question has been replaced by something more urgent: How [...]
3

Human in the Lead: Why the AI Advantage Belongs to Those Who Lead It

/0 Comments/in
AI is rapidly entering life sciences. Research, medical writing, regulatory affairs, market access — few functions are untouched by the conversation. The technology is advancing fast, investment is accelerating, and the pressure to act is real. But speed of adoption and quality of results are not the same thing. And in a highly regulated industry [...]
4

Why Pharma Can’t Afford Good Enough AI

/0 Comments/in
Why Pharma Can't Afford 'Good Enough' AI Generic AI tools like ChatGPT and Microsoft Copilot are rapidly being adopted across pharmaceutical organizations, with teams expecting them to handle complex use cases involving internal medical data. Yet despite their promise, these tools frequently fall short in pharmaceutical, biotech, and medtech environments. While they excel at general [...]
5

OneRay Key Updates Delivering Next-Generation GenAI Capabilities

/0 Comments/in
OneRay Key Updates Delivering Next-Generation GenAI Capabilities   Our private gen AI solution OneRay comes with significant updates in Version 3, introducing enhanced AI capabilities and an expanded suite of specialized agents for pharmaceutical knowledge work. We're pleased to share the key updates now available in OneRay Version 3, delivering a series of transformative enhancements [...]
7

Generative AI is set to transform medical affairs

/0 Comments/in
Generative AI is set to transform medical affairs' strategic approach to patient impact. Generative AI is a transformative force reshaping how we approach patient care in Pharma, Biotech, and Medtech. At FFI Ventures, we’re leading this change, empowering and accelerating Medical Affairs teams as they transition from strategy design to real-world use case implementation. We’re [...]
8

Maximizing HCP engagement: the omnichannel advantage

/0 Comments/in
Maximizing HCP engagement: the omnichannel advantage Coping with increasingly restrictive access to the audience, a vast range of different interests in products and services, and the average human attention span now reduced to a mere 8 seconds, pharmaceutical companies continue to build seamless, integrated customer experiences across preferred online and offline channels. The core objective [...]
9

Continuous Evolution and Value-Add of Our Gen AI Agents

/0 Comments/in
Continuous Evolution and Value-Add of Our Gen AI Agents Our generative AI agents, or "bots" that we co-create with and implement in Pharma, Biotech & Medtech organizations are multi-talented, able to take on a wide range of business tasks and challenges. These agents are pre-trained and validated by domain experts before releasing to teams or [...]
10

Private generative AI is rapidly delivering value for Pharma

/0 Comments/in
Private generative AI is rapidly delivering value for Pharma As companies make progress with generative AI, they are increasingly capturing and delivering value. Specific examples in 2024 include Lilly, Sanofi, Pfizer, Roche, Boehringer Ingelheim, Novo Nordisk and aiCure). Generative AI has the potential to revolutionize the pharma and biotech industry. By applying this technology to [...]